ARCHIVES

House Measure Would Eliminate AHRQ, Rescind PCORI, Cut Outcomes Research, And Halt NIH’s Title 42 Hiring Program

This article is from The Cancer Letter archive.

Vol. 38 No. 29 | July 20, 2012

Download PDF Visit The Full Archive

Related Articles

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

October 28, 2011

NCI Program Develops Bioinformatics Tool To Design Cancer Drugs

September 13, 2002

No difference between digital or film mammograms, study finds.

September 23, 2005

OMB Ploy Would Delay Funding 1,500 NIH Grants From FY 1985 To 1986; Other Cuts Are Considered

January 18, 1985

Varmus: Why are scientific societies obstructing public access to research results?

May 20, 2005